| 000 | 01518 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517052049.0 | ||
| 264 | 0 | _c20160720 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1881-1469 | ||
| 024 | 7 |
_a10.1038/ja.2015.94 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKakeya, Hideaki | |
| 245 | 0 | 0 |
_aRQN-18690A (18-deoxyherboxidiene) targets SF3b, a spliceosome component, and inhibits angiogenesis. _h[electronic resource] |
| 260 |
_bThe Journal of antibiotics _cFeb 2016 |
||
| 300 |
_a121-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFatty Alcohols _xpharmacology |
| 650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
| 650 | 0 | 4 |
_aPhosphoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrans _xpharmacology |
| 650 | 0 | 4 | _aRNA Splicing Factors |
| 650 | 0 | 4 |
_aRibonucleoprotein, U2 Small Nuclear _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSpliceosomes _xdrug effects |
| 700 | 1 | _aKaida, Daisuke | |
| 700 | 1 | _aSekiya, Hiromi | |
| 700 | 1 | _aNagai, Koji | |
| 700 | 1 | _aYoshida, Minoru | |
| 700 | 1 | _aOsada, Hiroyuki | |
| 773 | 0 |
_tThe Journal of antibiotics _gvol. 69 _gno. 2 _gp. 121-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ja.2015.94 _zAvailable from publisher's website |
| 999 |
_c25242632 _d25242632 |
||